Mannose-binding lectin gene 2 variant DD (rs 5030737) is associated with susceptibility to COVID-19 infection in the urban population of Patna City (India)

Abstract The study aimed to measure plasma levels of Mannose-Binding Lectin (MBL) and MBL-associated serine protease-2 (MASP-2) and their polymorphisms in COVID-19 patients and controls to detect association. As MBL is a protein of immunological importance, it may contribute to the first-line host defence against SARS-CoV-2. MBL initiates the lectin pathway of complement activation with help of MASP-1 and MASP-2. Hence, appropriate serum levels of MBL and MASPs are crucial in getting protection from the disease. The polymorphisms of MBL and MASP genes affect their plasma levels, impacting their protective function and thus may manifest susceptibility, extreme variability in the clinical symptoms and progression of COVID-19 disease. The present study was conducted to find plasma levels and genetic variations in MBL and MASP-2 in COVID-19 patients and controls using PCR–RFLP and ELISA, respectively.The present study was conducted to find plasma levels and genetic variations in MBL and MASP-2 in COVID-19 patients and controls using PCR–RFLP and ELISA, respectively. Our results indicate that median serum levels of MBL and MASP-2 were significantly low in diseased cases but attained normal levels on recovery. Only genotype DD was found to be associated with COVID-19 cases in the urban population of Patna city..

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:298

Enthalten in:

Molecular genetics and genomics - 298(2023), 4 vom: 18. Mai, Seite 955-963

Sprache:

Englisch

Beteiligte Personen:

Sharma, Sadhana [VerfasserIn]
Kumari, Bandana [VerfasserIn]
Ali, Asgar [VerfasserIn]
Patel, Pankaj Kumar [VerfasserIn]
Sharma, Abhay Kumar [VerfasserIn]
Nair, Rathish [VerfasserIn]
Singh, Prabhat Kumar [VerfasserIn]
Hajela, Krishnan [VerfasserIn]

Links:

Volltext [lizenzpflichtig]

Themen:

COVID-19
MASP-2
MBL genotyping
SARS-COV-2

Anmerkungen:

© The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

doi:

10.1007/s00438-023-02030-4

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

SPR051688603